Human Genome Sciences
Human Genome Sciences is a biopharmaceutical company that specializes in the development of innovative pharmaceutical products through genomic research. The company is focused on advancing its pipeline of therapies, with three products currently in late-stage clinical development. By leveraging genomic insights, Human Genome Sciences aims to address unmet medical needs and improve patient outcomes in various therapeutic areas.
1 past transactions
CoGenesys
Series A in 2006
CoGenesys is a biopharmaceutical company dedicated to the development of peptide- and protein-based therapeutics. It focuses on creating innovative medicines to address a range of diseases, including cancer, cardiovascular, metabolic, infectious, autoimmune, and central nervous system disorders. The company conducts clinical trials to establish the safety and efficacy of its compounds, and subsequently pursues selective licensing or partnerships to secure funding for further development of its products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.